Scientists at Wake Forest University School of Medicine have discovered a new way to kill cancer cells by blocking their ...
TipRanks on MSN
Imagion Biosystems Advances HER2 Breast Cancer Imaging with Positive Phase 2 Trial Results
An update from Imagion Biosystems Ltd. ( ($AU:IBX) ) is now available. Imagion Biosystems has announced positive results from its collaboration ...
A new Lancet Oncology Commission highlights a growing "human crisis" in cancer care. Despite advances in treatment and ...
Treatment innovations in advanced lung cancer and melanoma over the past 2 decades have significantly improved OS, but they ...
Agenus Inc. (($AGEN)) announced an update on their ongoing clinical study. A recent clinical study update from Agenus Inc. (AGEN) focuses on the ...
When facing a lymphoma diagnosis, understanding the available treatment options becomes crucial for patients navigating this challenging journey. Lymphoma, a cancer affecting the immune system’s ...
The study is testing INBRX-106, a hexavalent OX40 agonist antibody, designed to enhance the immune response against tumors. It is administered alone or with pembrolizumab, a well-known anti-PD-1 ...
Over the past generation, advances in treating common cancers—breast, lung, melanoma, and gastrointestinal (GI)—have improved ...
Sellas Life Sciences Group Inc. (NASDAQ:SLS) is a biotechnology company that develops novel cancer therapies. Its lead ...
Researchers present an overview of treatment and management strategies for patients with HR+/HER2+ breast cancer, including common adverse effects.
Lung Cancer Awareness Month began over the weekend, and one cancer survivor has also begun a journey of spreading awareness ...
Fear of cancer, treatment side effects and misconceptions about masculinity may prevent men from prioritising their health, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results